Available drugs and supplements for rapid deployment for treatment of COVID-19

J Mol Cell Biol. 2021 Jul 6;13(3):232-236. doi: 10.1093/jmcb/mjab002.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / chemistry
  • Adenosine Monophosphate / pharmacokinetics
  • Adenosine Monophosphate / therapeutic use
  • Alanine / analogs & derivatives
  • Alanine / chemistry
  • Alanine / pharmacokinetics
  • Alanine / therapeutic use
  • Animals
  • COVID-19 / blood
  • COVID-19 / virology
  • COVID-19 Drug Treatment*
  • Disease Models, Animal
  • Drug Repositioning / trends*
  • Flavonoids / chemistry
  • Flavonoids / pharmacokinetics
  • Flavonoids / therapeutic use
  • Humans
  • Mice
  • Nitro Compounds / chemistry
  • Nitro Compounds / pharmacokinetics
  • Nitro Compounds / therapeutic use
  • Pharmaceutical Preparations
  • SARS-CoV-2 / drug effects*
  • SARS-CoV-2 / pathogenicity
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacokinetics
  • Small Molecule Libraries / therapeutic use*
  • Teicoplanin / analogs & derivatives
  • Teicoplanin / chemistry
  • Teicoplanin / pharmacokinetics
  • Teicoplanin / therapeutic use
  • Thiazoles / chemistry
  • Thiazoles / pharmacokinetics
  • Thiazoles / therapeutic use

Substances

  • Flavonoids
  • Nitro Compounds
  • Pharmaceutical Preparations
  • Small Molecule Libraries
  • Thiazoles
  • baicalin
  • remdesivir
  • Adenosine Monophosphate
  • Teicoplanin
  • dalbavancin
  • Alanine
  • nitazoxanide